loading
전일 마감가:
$1.19
열려 있는:
$1.2
하루 거래량:
85,792
Relative Volume:
0.08
시가총액:
$140.65M
수익:
$4.35M
순이익/손실:
$-45.53M
주가수익비율:
-1.0833
EPS:
-1.08
순현금흐름:
$-44.79M
1주 성능:
-5.95%
1개월 성능:
-22.04%
6개월 성능:
+50.38%
1년 성능:
+36.36%
1일 변동 폭
Value
$1.175
$1.2094
1주일 범위
Value
$1.13
$1.27
52주 변동 폭
Value
$0.7201
$1.80

Lucid Diagnostics Inc Stock (LUCD) Company Profile

Name
명칭
Lucid Diagnostics Inc
Name
전화
212 949 4319
Name
주소
360 MADISON AVENUE, NEW YORK
Name
직원
70
Name
트위터
Name
다음 수익 날짜
2025-03-24
Name
최신 SEC 제출 서류
Name
LUCD's Discussions on Twitter

LUCD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
LUCD
Lucid Diagnostics Inc
1.18 140.65M 4.35M -45.53M -44.79M -1.08
Medical Devices icon
ABT
Abbott Laboratories
133.47 233.36B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
105.34 147.06B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
391.21 145.64B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
85.90 112.76B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.06 44.46B 5.54B 4.18B 623.10M 7.00

Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-12-27 개시 Ascendiant Capital Markets Buy
2021-11-08 개시 BTIG Research Buy
2021-11-08 개시 Cantor Fitzgerald Overweight
2021-11-08 개시 Needham Buy

Lucid Diagnostics Inc 주식(LUCD)의 최신 뉴스

pulisher
Jun 18, 2025

Lucid Diagnostics Holds Annual Stockholders Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Leading California Hospital Network Launches Revolutionary 3-Minute Cancer Detection Test from Lucid Diagnostics - Stock Titan

Jun 18, 2025
pulisher
Jun 10, 2025

119,887 Shares in Lucid Diagnostics Inc. (NASDAQ:LUCD) Acquired by Citadel Advisors LLC - Defense World

Jun 10, 2025
pulisher
Jun 07, 2025

Ascendiant Capital Markets Issues Positive Forecast for Lucid Diagnostics (NASDAQ:LUCD) Stock Price - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Ascendiant Capital raises Lucid Diagnostics stock price target to $7.75 By Investing.com - Investing.com South Africa

Jun 06, 2025
pulisher
Jun 06, 2025

Ascendiant Capital raises Lucid Diagnostics stock price target to $7.75 - Investing.com Australia

Jun 06, 2025
pulisher
Jun 06, 2025

Lucid Diagnostics (LUCD) Stock Maintained at Buy by Ascendiant Capital | LUCD Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Lucid Diagnostics (LUCD) Target Price Increased by Ascendiant | - GuruFocus

Jun 06, 2025
pulisher
Jun 03, 2025

Lucid Diagnostics Files For Offering Of 36 Million Shares Of Common Stock - MarketScreener

Jun 03, 2025
pulisher
Jun 03, 2025

Pavmed's Veris Health Signs Long-Term Partnership Deal With Ohio State University Hospital - marketscreener.com

Jun 03, 2025
pulisher
May 30, 2025

Lucid Diagnostics Enters $25M Sales Agreement - TipRanks

May 30, 2025
pulisher
May 27, 2025

Lucid Diagnostics joins Russell 2000 and 3000 indexes - Mugglehead Magazine

May 27, 2025
pulisher
May 27, 2025

Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes - The Malaysian Reserve

May 27, 2025
pulisher
May 27, 2025

Lucid Diagnostics to Join Russell 2000, Russell 3000 Indexes - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

Lucid Diagnostics to join Russell 2000 and Russell 3000 indexes By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

Lucid Diagnostics to join Russell 2000 and Russell 3000 indexes - Investing.com Australia

May 27, 2025
pulisher
May 27, 2025

Lucid Diagnostics (LUCD) Joins Russell 2000 and Russell 3000 Indexes | LUCD Stock News - GuruFocus

May 27, 2025
pulisher
May 26, 2025

Lucid Diagnostics (LUCD) Joins Russell 2000 and Russell 3000 Ind - GuruFocus

May 26, 2025
pulisher
May 25, 2025

Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives $3.50 Consensus Price Target from Brokerages - Defense World

May 25, 2025
pulisher
May 24, 2025

Certain Options of Lucid Diagnostics Inc. are subject to a Lock-Up Agreement Ending on 25-MAY-2025. - marketscreener.com

May 24, 2025
pulisher
May 24, 2025

Certain Common Stock of Lucid Diagnostics Inc. are subject to a Lock-Up Agreement Ending on 25-MAY-2025. - marketscreener.com

May 24, 2025
pulisher
May 24, 2025

Insider Buying: Dennis Matheis Acquires 350,000 Shares of Lucid Diagnostics Inc (LUCD) - GuruFocus

May 24, 2025
pulisher
May 24, 2025

Certain Series B-1 Convertible Preferred Stock of Lucid Diagnostics Inc. are subject to a Lock-Up Agreement Ending on 25-MAY-2025. - MarketScreener

May 24, 2025
pulisher
May 23, 2025

Lucid Diagnostics (LUCD) Director Acquires Significant Shares | - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Lucid Diagnostics (LUCD) Director Acquires Significant Shares | LUCD Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Lucid Diagnostics Joins Elite Russell Indexes, Opens Door to $10.6T Investment Pool - Stock Titan

May 23, 2025
pulisher
May 22, 2025

Lucid Diagnostics Files Shelf Registration for Secondary Sale of 37 Million Shares by Convertible Note Holders - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Lucid Diagnostics (LUCD) Files to Sell 36.98 Million Shares | LU - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Lucid Diagnostics Files Prospectus For Potential Offer, Sale From Time To Time Of Up To 37 Million Shares Of Common Stock By Selling Stockholders - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Lucid Diagnostics (LUCD) Files to Sell 36.98 Million Shares | LUCD Stock News - GuruFocus

May 22, 2025
pulisher
May 20, 2025

Lucid Diagnostics’ SWOT analysis: stock faces reimbursement hurdles amid market potential - Investing.com Nigeria

May 20, 2025
pulisher
May 19, 2025

Cantor Fitzgerald maintains Lucid Diagnostics stock Overweight - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

Cantor Fitzgerald maintains Lucid Diagnostics stock Overweight By Investing.com - Investing.com India

May 19, 2025
pulisher
May 17, 2025

Lucid Diagnostics’ (LUCD) Buy Rating Reiterated at Needham & Company LLC - Defense World

May 17, 2025
pulisher
May 17, 2025

Cantor Fitzgerald Reiterates “Overweight” Rating for Lucid Diagnostics (NASDAQ:LUCD) - Defense World

May 17, 2025
pulisher
May 16, 2025

Lucid Diagnostics (LUCD) Stock Rating Reiterated by Cantor Fitzg - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Lucid Diagnostics signals expanded market reach and $41M pro forma cash following commercial and clinical advances - MSN

May 16, 2025
pulisher
May 16, 2025

Analysts Offer Insights on Healthcare Companies: Nuvation Bio (NUVB), Lucid Diagnostics (LUCD) and Arcellx Inc (ACLX) - The Globe and Mail

May 16, 2025
pulisher
May 16, 2025

Lucid Diagnostics Reports Increased Losses Amid Revenue Decline - TipRanks

May 16, 2025
pulisher
May 15, 2025

Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 15, 2025
pulisher
May 15, 2025

Cantor maintains Lucid Diagnostics stock with $2 target after Q1 results - Investing.com Australia

May 15, 2025
pulisher
May 15, 2025

Lucid Diagnostics (LUCD) Stock Rating Reiterated by Cantor Fitzgerald | LUCD Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Transcript : PAVmed Inc., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

PAVmed Inc Q1 2025 Earnings: Revenue Surges to $0.8 Million, Bea - GuruFocus

May 15, 2025
pulisher
May 15, 2025

PAVmed Provides Business Update and Reports First Quarter 2025 F - GuruFocus

May 15, 2025
pulisher
May 15, 2025

PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results | PAVM Stock News - GuruFocus

May 15, 2025

Lucid Diagnostics Inc (LUCD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Lucid Diagnostics Inc 주식 (LUCD) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Matheis Dennis
Director
May 21 '25
Buy
1.32
129,684
171,520
316,782
Matheis Dennis
Director
May 22 '25
Buy
1.32
33,218
43,795
350,000
$306.37
price down icon 0.23%
medical_devices PHG
$23.93
price up icon 0.25%
medical_devices STE
$238.87
price up icon 0.02%
$84.92
price up icon 0.20%
$75.21
price up icon 0.44%
medical_devices EW
$77.05
price up icon 0.36%
자본화:     |  볼륨(24시간):